Clinical trial Recruiting at 1 site Phase 2 Interventional Ages 8 to 17

Exercise therapy and activity modification for Sever’s disease in kids

Official title: Exercise Therapy and Physical Activity Modification for Patients With Sever's Disease: A Randomized Controlled Trial

Run by California State University, Fullerton · NCT07928232 · Data updated 2026-11-12

This study tests whether a structured exercise program plus activity tweaks can reduce heel pain and improve function in children with Sever’s disease.

Quick facts

PhasePhase 2
Study typeInterventional
Ages8 Years to 17 Years
SexAll
Enrollment60 (estimated)
SponsorCalifornia State University, Fullerton
Academic / other
Locations1 site (Fullerton, California)
StatusRecruiting
StartedOctober 30, 2025
Main results expectedJuly 1, 2028
Study endsJuly 2028
Registry record updatedNovember 10, 2026
Trial IDNCT07928232 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal participants are youths with insidious heel pain and positive findings on calcaneal or Achilles palpation, who can run or jump with pain.

Probably not a fit

Patients whose pain does not respond to exercise or who have contraindicating conditions may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Sever’s disease is an overuse injury at the heel growth plate in youth. The trial compares a comprehensive exercise rehabilitation with a non-exercise palliative approach over 12 weeks to see if pain, function, and tissue structure improve. Outcomes include pain and lower-extremity function, muscle and tendon structure, and overall physical activity. The study uses an interventional design with exercise as the active component and an active control for comparison. Recruitment is centered at a university kinesiology facility in Fullerton, CA.

Why it matters

Potential benefit: If successful, the program could shorten symptoms and improve sports participation and quality of life for affected youth.

How similar studies have gone: Previous evidence supports exercise for growth plate injuries, but high-quality data for Sever’s disease remain limited; this study adds to growing but still relatively novel evidence.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Insidious onset of heel pain over several weeks
* Pain on palpation of the calcaneus or Achilles tendon
* Complaint of heel pain with running or jumping activities.

Exclusion Criteria:

* Any underlying condition predisposing heel pain (i.e., spina bifida, osteogenesis imperfecta, Larsen syndrome, cerebral palsy)
* Any other injury that limits their ability to run or jump.

Where it's running

  • Kinesiology and Health Sciences Building
    Fullerton, California, United States
    Recruiting

Study contacts

  • Principal investigator: Shawn L Hanlon, PhD — California State University, Fullerton
  • Study coordinator: Shawn L Hanlon, PhD
  • Email: shanlon@fullerton.edu
  • Phone: 657-278-5869

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.